Yen‐Hao Su
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- Surgery 12
- Bariatric Surgery and Outcomes 9
- Co-authors
- Yun Chen (5 shared papers)Sheng-Hong Tseng (3 shared papers)Po‐Huang Lee (3 shared papers)Hong‐Shiee Lai (2 shared papers)Jin‐Tung Liang (2 shared papers)Swei-Ming Lin (1 shared paper)Hsin‐Yi Huang (1 shared paper)Ming-Shian Tsai (1 shared paper)
- Journals
- Obesity Surgery (4 papers)Aging (4 papers)Journal of Cellular Physiology (3 papers)Annals of Surgical Oncology (3 papers)Oncotarget (2 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Yen‐Hao Su
53 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Geriatrics and Gerontology 132
- Cancer Research 225
- Hepatology 70
- Oncology 204
- Molecular Biology 426
Countries citing papers authored by Yen‐Hao Su
This map shows the geographic impact of Yen‐Hao Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yen‐Hao Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yen‐Hao Su more than expected).
Fields of papers citing papers by Yen‐Hao Su
This network shows the impact of papers produced by Yen‐Hao Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yen‐Hao Su. The network helps show where Yen‐Hao Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Yen‐Hao Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 177 | |
| 2 | 2006 | 146 | |
| 3 | 2012 | 111 | |
| 4 | 2010 | 91 | |
| 5 | 2015 | 52 | |
| 6 | 2015 | 43 | |
| 7 | 2015 | 38 | |
| 8 | 2018 | 34 | |
| 9 | 2016 | 30 | |
| 10 | 2021 | 28 | |
| 11 | 2014 | 25 | |
| 12 | 2013 | 24 | |
| 13 | 2014 | 24 | |
| 14 | 2014 | 24 | |
| 15 | Celecoxib increased expression of 14-3-3sigma and induced apoptosis of glioma cells. | 2007 | 19 |
| 16 | 2020 | 18 | |
| 17 | 2015 | 18 | |
| 18 | 2006 | 16 | |
| 19 | Induction of apoptosis and cell cycle arrest in glioma cells by GL331 (a topoisomerase II inhibitor). | 2006 | 15 |
| 20 | 2023 | 14 |
About Yen‐Hao Su
Yen‐Hao Su is a scholar working on Molecular Biology, Surgery, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.1k indexed citations. Recurring topics across this work include Bariatric Surgery and Outcomes (9 papers), MicroRNA in disease regulation (9 papers), Cancer Cells and Metastasis (4 papers), Circular RNAs in diseases (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Geriatrics and Gerontology (132 citations), Cancer Research (225 citations), Hepatology (70 citations), Oncology (204 citations) and Molecular Biology (426 citations). Yen‐Hao Su has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Yun Chen, Sheng-Hong Tseng, Po‐Huang Lee, Hong‐Shiee Lai, Jin‐Tung Liang, Swei-Ming Lin, Hsin‐Yi Huang, Ming-Shian Tsai, Ming‐Chih Ho and Wei‐Jei Lee. Their work appears in journals such as Obesity Surgery, Aging, Journal of Cellular Physiology, Annals of Surgical Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.